Ethacrynic acid (tablet)

Ethacrynic acid (tablet)

File:Ethacrynic acid.svg
Pharmacokinetic data
Protein binding	> 98%
Identifiers
IUPAC name 2-[2,3-dichloro-4-(2-methylidenebutanoyl) phenoxy] acetic acid
CAS Number	58-54-8
PubChem CID	3278
DrugBank	APRD00251
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C13H12Cl2O4
Molar mass	303.137 g/mol

Ethacrynic acid (trade name Edecrin) is a loop diuretic medication used to treat high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure, and kidney failure. Unlike the other loop diuretics, ethacrynic acid is not a sulfonamide and thus, its use is not contraindicated in those with sulfur allergies. Ethacrynic acid is a phenoxyacetic acid derivative containing a ketone and a methylene group. A cysteine adduct is formed with the methylene group and this is the active form.

Administration

25 mg and 50 mg tablets are available for oral use. The sodium salt (ethacrynate sodium) can also be given intravenously.

Side effects

As a diuretic, ethacrynic acid can cause frequent urination, but this usually resolves after taking the drug for a few weeks.

Ethacrynic acid can also cause low potassium levels, which may manifest as muscle cramps or weakness. It has also been known to cause reversible or permanent hearing loss and liver damage. On oral administration, it produces diarrhea; intestinal bleeding may occur at higher doses.

Template:Pharma-stub

MECHANISM OF ACTION Acts by inhibiting sodim-potassium-chloride cotransport in the ascending loop of Henle. Loss of potassium ions is less marked but chances of hypochloremic alkalosis are greater. The dose response curve of ethacrynic acid is steeper than that of furosemide and, in general, it is less manageable; dose range is 50-150mg.